A. Srivastava, C. Mason, E. Wagena, N. Cuende, D. J. Weiss et al., Part 1: Defining unproven cellular therapies, Cytotherapy, vol.18, pp.117-126, 2016.

D. J. Weiss, J. Rasko, N. Cuende, M. A. Ruiz, H. Ho et al., Making the "unproven" "proven, Cytotherapy, vol.2, pp.120-123, 2016.

O. Donnell, L. Turner, L. Levine, and A. D. , Part 6: The role of communication in better understanding unproven cellular therapies, Cytotherapy, vol.18, pp.143-151, 2016.

K. Nichols, W. Janssen, D. Wall, N. Cuende, and D. Griffin, Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks, Cytotherapy, vol.18, pp.127-164, 2016.

P. Eldridge, D. Griffin, W. Janssen, and L. O'donnell, Understanding the manufacturing of unproven cellular therapy products, Cytotherapy, vol.3, pp.124-130, 2016.

R. J. Deans, K. C. Gunter, M. Dominici, and M. Forte, Part 5: Unproven cell therapies and the commercialization of cellbased products, Cytotherapy, vol.18, pp.138-180, 2016.

A. L. Berkowitz, M. B. Miller, S. A. Mir, D. Cagney, V. Chavakula et al., Glioproliferative Lesion of the Spinal Cord as a Complication of "Stem-Cell Tourism, N Engl J Med, vol.375, pp.196-204, 2016.

A. E. Kuriyan, T. A. Albini, J. H. Townsend, M. Rodriguez, H. K. Pandya et al., Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD, N Engl J Med, vol.376, pp.1047-53, 2017.

M. Dominici, K. Nichols, A. Srivastava, D. J. Weiss, P. Eldridge et al., Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective, Cytotherapy, vol.17, pp.1663-1669, 2015.

. Fda-quackdown-n, , 2018.

F. and C. , Regulatory Considerations for Human Cell, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff, 2017.

F. C. , Expedited Programs for Regenerative Medicine Therapies for Serious Conditions; Draft Guidance for Industry, 2017.

F. , C. , and C. , Guidance for Industry Expedited Programs for Serious Conditions À Drugs and Biologics, p.17, 2017.

M. Ng, S. Song, N. S. Piuzzi, K. Ng, C. Gwam et al., Stem cell industry update: 2012 to 2016 reveals accelerated investment, but market capitalization and earnings lag, Cytotherapy, vol.19, pp.1131-1140, 2017.

N. Piuzzi, M. Ng, M. Chughtai, A. Khlopas, K. Ng et al., The Stem-Cell Market for the Treatment of Knee Osteoarthritis: A Patient Perspective, J Knee Surg, vol.31, pp.551-557, 2018.

P. N. Ramkumar, S. M. Navarro, H. S. Haeberle, M. Chughtai, C. Demetriades et al., Cellular therapy injections in today's orthopedic market: A social media analysis, Cytotherapy, vol.19, pp.1392-1401, 2017.

J. Chahla, N. S. Piuzzi, J. J. Mitchell, C. S. Dean, C. Pascual-garrido et al., Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee, J Bone Jt Surg, vol.98, pp.1511-1532, 2016.

H. I. Pas, M. Winters, H. J. Haisma, M. J. Koenis, J. L. Tol et al., Stem cell injections in knee osteoarthritis: a systematic review of the literature, Br J Sports Med, vol.51, pp.1125-1158, 2017.

N. S. Piuzzi, J. Chahla, J. B. Schrock, R. F. Laprade, C. Pascualgarrido et al., Evidence for the Use of CellBased Therapy for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature

, J Arthroplasty, vol.32, pp.1698-708, 2017.

N. S. Piuzzi, J. Chahla, H. Jiandong, M. Chughtai, R. F. Laprade et al., Analysis of Cell Therapies Used in Clinical Trials for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature

, J Arthroplasty, vol.32, pp.2612-2620, 2017.

N. Piuzzi, A. Khlopas, J. Newman, M. Ng, M. Roche et al., Bone Marrow Cellular Therapies: Novel Therapy for Knee Osteoarthritis, J Knee Surg, vol.31, pp.22-28, 2018.

N. Piuzzi, M. Chughtai, A. Khlopas, S. Harwin, A. Miniaci et al., Platelet-Rich Plasma for the Treatment of ARTICLE, PRESS Proceedings, p.15

, Knee Osteoarthritis: A Review, J Knee Surg, vol.30, pp.627-660, 2017.

R. S. Marcucio, A. Nauth, P. V. Giannoudis, C. Bahney, N. S. Piuzzi et al., Stem Cell Therapies in Orthopaedic Trauma, J Orthop Trauma, vol.29, pp.24-31, 2015.

Y. Khan, M. J. Yaszemski, A. G. Mikos, and C. T. Laurencin, Tissue engineering of bone: material and matrix considerations, J Bone Joint Surg Am, vol.90, pp.36-42, 2008.

M. A. Imam, J. Holton, L. Ernstbrunner, W. Pepke, F. Grubhofer et al., A systematic review of the clinical applications and complications of bone marrow aspirate concentrate in management of bone defects and nonunions, Int Orthop, vol.41, issue.11, pp.2213-2233, 2017.

A. I. Hoch and J. K. Leach, Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications, Stem Cells Transl Med, vol.3, pp.643-52, 2014.

H. C. Fayaz, P. V. Giannoudis, M. S. Vrahas, R. M. Smith, C. Moran et al., The role of stem cells in fracture healing and nonunion, Int Orthop, vol.35, pp.1587-97, 2011.

T. L. Arinzeh, S. J. Peter, M. P. Archambault, C. Van-den-bos, S. Gordon et al., Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect, J Bone Joint Surg Am, vol.85, pp.1927-1962, 2003.

B. Skovrlj, J. Z. Guzman, A. Maaieh, M. Cho, S. K. Iatridis et al., Cellular bone matrices: viable stem cell-containing bone graft substitutes, Spine J, vol.14, pp.2763-72, 2014.

T. ,

D. B. Musante, M. E. Firtha, B. L. Atkinson, R. Hahn, J. T. Ryaby et al., Clinical evaluation of an allogeneic bone matrix containing viable osteogenic cells in patients undergoing one-and two-level posterolateral lumbar arthrodesis with decompressive laminectomy, J Orthop Surg Res, vol.11, p.63, 2016.

T. A. Peppers, D. E. Bullard, J. S. Vanichkachorn, S. K. Stanley, P. M. Arnold et al., Prospective clinical and radiographic evaluation of an allogeneic bone matrix containing stem cells (Trinity Evolution Ò Viable Cellular Bone Matrix) in patients undergoing two-level anterior cervical discectomy and fusion, J Orthop Surg Res, vol.12, p.67, 2017.

J. Vanichkachorn, T. Peppers, D. Bullard, S. K. Stanley, R. J. Linovitz et al., A prospective clinical and radiographic 12-month outcome study of patients undergoing singlelevel anterior cervical discectomy and fusion for symptomatic cervical degenerative disc disease utilizing a novel viable allogeneic, cancellous, bone matrix (trinity evolution TM ) with a comparison to historical controls, Eur Spine J, vol.25, pp.2233-2241, 2016.

G. F. Muschler, C. Nakamoto, and L. G. Griffith, Engineering principles of clinical cell-based tissue engineering, J Bone Joint Surg Am, vol.86, pp.1541-58, 2004.

G. F. Muschler, R. J. Midura, and C. Nakamoto, Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics, J Biomed Biotechnol, pp.170-93, 2003.

T. E. Patterson, K. Kumagai, L. Griffith, and G. F. Muschler, Cellular strategies for enhancement of fracture repair, J Bone Joint Surg Am, vol.90, pp.111-120, 2008.

D. J. Hak, D. Fitzpatrick, J. A. Bishop, J. L. Marsh, S. Tilp et al., Delayed union and nonunions: epidemiology, clinical issues, and financial aspects, Injury, vol.45, pp.3-7, 2014.

T. A. Einhorn and L. C. Gerstenfeld, Fracture healing: mechanisms and interventions, Nat Rev Rheumatol, vol.11, pp.45-54, 2014.

J. I. Dawson, J. Kanczler, R. Tare, M. Kassem, and R. Oreffo, Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies-where are we now?, Stem Cells, vol.32, pp.35-44, 2014.

R. Zura, Z. Xiong, T. Einhorn, J. T. Watson, R. F. Ostrum et al., Epidemiology of Fracture Nonunion in 18 Human Bones, JAMA Surg, vol.151, 2016.

T. E. Patterson, C. Boehm, C. Nakamoto, R. Rozic, E. Walker et al., The Efficiency of Bone Marrow Aspiration for the Harvest of Connective Tissue Progenitors from the Human Iliac Crest, J Bone Jt Surg, vol.99, pp.1673-82, 2017.

V. Luangphakdy, C. Boehm, H. Pan, J. Herrick, P. Zaveri et al., Assessment of Methods for Rapid Intraoperative Concentration and Selection of Marrow-Derived Connective Tissue Progenitors for Bone Regeneration Using the Canine Femoral Multidefect Model, Tissue Eng Part A, vol.22, pp.17-30, 2016.

T. Caralla, P. Joshi, S. Fleury, V. Luangphakdy, K. Shinohara et al., In Vivo Transplantation of Autogenous Marrow-Derived Cells Following Rapid Intraoperative Magnetic Separation, Tissue Eng Part A, vol.19, pp.125-159, 2013.

H. Kotlarz, C. L. Gunnarsson, H. Fang, and J. A. Rizzo, Insurer and outof-pocket costs of osteoarthritis in the US: evidence from national survey data, Arthritis Rheum, vol.60, pp.3546-53, 2009.

M. Lespasio, A. A. Sultan, N. S. Piuzzi, A. Khlopas, M. E. Husni et al., Hip Osteoarthritis: A Primer, Perm J, vol.22, pp.85-90, 2018.

J. M. Jordan, C. G. Helmick, J. B. Renner, G. Luta, A. D. Dragomir et al., Prevalence of Hip Symptoms and Radiographic and Symptomatic Hip Osteoarthritis in African Americans and Caucasians: The Johnston County Osteoarthritis Project, J Rheumatol, vol.36, pp.809-824, 2009.

B. J. Cole, C. Pascual-garrido, and R. C. Grumet, Surgical management of articular cartilage defects in the knee, Instr Course Lect, vol.59, pp.181-204, 2010.

C. J. Moran, C. Pascual-garrido, S. Chubinskaya, H. G. Potter, R. F. Warren et al., Restoration of Articular Cartilage, J Bone Jt Surg, vol.96, pp.336-380, 2014.

V. P. Mantripragada, W. A. Bova, C. Boehm, N. S. Piuzzi, N. A. Obuchowski et al., Progenitor cells from different zones of human cartilage and their correlation with histopathological osteoarthritis progression, J Orthop Res, vol.36, pp.1728-1766, 2018.

Y. Jiang and R. S. Tuan, Origin and function of cartilage stem/progenitor cells in osteoarthritis, Nat Rev Rheumatol, vol.11, pp.206-218, 2015.

Y. Jiang, Y. Cai, W. Zhang, Z. Yin, C. Hu et al., Human Cartilage-Derived Progenitor Cells From Committed Chondrocytes for Efficient Cartilage Repair and Regeneration, Stem Cells Transl Med, vol.5, pp.733-777, 2016.
DOI : 10.5966/sctm.2015-0192
URL : https://stemcellsjournals.onlinelibrary.wiley.com/doi/pdf/10.5966/sctm.2015-0192

K. L. Caldwell and J. Wang, Cell-based articular cartilage repair: the link between development and regeneration

A. In-press,

N. S. Piuzzi,

, Osteoarthr Cartil, vol.23, pp.351-62, 2015.

J. Chahla, N. S. Piuzzi, J. J. Mitchell, C. S. Dean, C. Pascual-garrido et al., Intra-Articular Cellular Therapy for Osteoarthritis and Focal Cartilage Defects of the Knee: A Systematic Review of the Literature and Study Quality Analysis, J Bone Joint Surg Am, vol.98, pp.1511-1532, 2016.

Y. Nam, Y. A. Rim, J. Lee, and J. H. Ju, Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration, Stem Cells Int, p.8490489, 2018.

J. Rehman, D. Traktuev, J. Li, S. Merfeld-clauss, C. J. Temmgrove et al., Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells, Circulation, vol.109, pp.1292-1300, 2004.

B. Usunier, M. Benderitter, R. Tamarat, and A. Chapel, Management of fibrosis: the mesenchymal stromal cells breakthrough, Stem Cells Int, p.340257, 2014.

N. S. Piuzzi, Z. B. Hussain, J. Chahla, M. E. Cinque, G. Moatshe et al., Variability in the Preparation, Reporting, and Use of Bone Marrow Aspirate Concentrate in Musculoskeletal Disorders, J Bone Jt Surg, vol.100, pp.517-542, 2018.

Y. Pers, M. Ruiz, D. No?-el, and C. Jorgensen, Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives, Osteoarthr Cartil, vol.23, pp.2027-2062, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01834450

M. Yubo, L. Yanyan, L. Li, S. Tao, L. Bo et al., Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: a meta-analysis, PLoS One, vol.12, 2017.

K. Takayama, Y. Kawakami, M. Kobayashi, N. Greco, J. H. Cummins et al., Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis, Arthritis Res Ther, vol.16, p.482, 2014.

L. Ipseiz, N. Espinosa-carrasco, G. Caicedo, A. Tejedor, G. Toupet et al., PPARb/d directs the therapeutic potential of mesenchymal stem cells in arthritis, Ann Rheum Dis, vol.75, pp.2166-74, 2016.

J. Bekkers, A. I. Tsuchida, M. Van-rijen, L. A. Vonk, W. Dhert et al., Single-Stage Cell-Based Cartilage Regeneration Using a Combination of Chondrons and Mesenchymal Stromal Cells, Am J Sports Med, vol.41, pp.2158-66, 2013.

M. F. Rai, L. J. Sandell, B. Zhang, R. W. Wright, and R. H. Brophy, RNA Microarray Analysis of Macroscopically Normal Articular Cartilage from Knees Undergoing Partial Medial Meniscectomy: Potential Prediction of the Risk for Developing Osteoarthritis, PLoS One, vol.11, 2016.

X. Shang, Z. Wang, and H. Tao, Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain, Ther Clin Risk Manag, vol.13, pp.951-957, 2017.

Z. Jotanovic, R. Mihelic, B. Sestan, and Z. Dembic, Role of Interleukin-1 Inhibitors in Osteoarthritis, Drugs Aging, vol.29, pp.343-58, 2012.

S. S. Adkar, J. M. Brunger, V. P. Willard, C. Wu, C. A. Gersbach et al., Genome Engineering for Personalized Arthritis Therapeutics, Trends Mol Med, vol.23, pp.917-948, 2017.

S. Lyman, N. Nakamura, B. J. Cole, C. Erggelet, A. H. Gomoll et al., Cartilage-Repair Innovation at a Standstill: Methodologic and Regulatory Pathways to Breaking Free, J Bone Joint Surg Am, vol.98, 2016.

J. O. Ho, P. Sawadkar, and V. Mudera, A review on the use of cell therapy in the treatment of tendon disease and injuries, Journal of Tissue Engineering, vol.5, pp.1-18, 2014.

Z. Yin, J. Guo, T. Wu, X. Chen, L. Xu et al., Stepwise Differentiation of Mesenchymal Stem Cells Augments Tendon-Like Tissue Formation and Defect Repair In Vivo, Stem Cells Transl Med, vol.5, pp.1106-1122, 2016.

Z. Yin, J. Hu, Y. L. Zheng, Z. An, C. Wu et al., Single-cell analysis reveals a nestin+ tendon stem/progenitor cell population with strong tenogenic potentiality, Sci Adv, vol.2, 2016.

J. Chen, E. Zhang, W. Zhang, Z. Liu, P. Lu et al., Fos Promotes Early Stage Teno-Lineage Differentiation of Tendon Stem/Progenitor Cells in Tendon, Stem Cells Transl Med, vol.6, pp.2009-2028, 2017.

H. Liu, C. Zhang, S. Zhu, P. Lu, T. Zhu et al., Mohawk promotes the tenogenesis of mesenchymal stem cells through activation of the TGFb signaling pathway, Stem Cells, vol.33, pp.443-55, 2015.

X. X. Cong, X. S. Rao, J. X. Lin, X. C. Liu, G. A. Zhang et al., Activation of AKT-mTOR Signaling Directs Tenogenesis of Mesenchymal Stem Cells, Stem Cells, vol.36, pp.527-566, 2018.

Y. Zhang, X. Chen, G. Li, K. Chan, B. C. Heng et al., Concise Review: Stem Cell Fate Guided By Bioactive Molecules for Tendon Regeneration, Stem Cells Transl Med, vol.7, pp.17-0206, 2018.

R. S. Stilhano, L. Martins, S. Ingham, J. B. Pesquero, and J. Huard, Gene and cell therapy for muscle regeneration, Curr Rev Musculoskelet Med, vol.8, pp.182-189, 2015.

S. Terada, S. Ota, M. Kobayashi, T. Kobayashi, Y. Mifune et al., Use of an Antifibrotic Agent Improves the Effect of Platelet-Rich Plasma on Muscle Healing After Injury, J Bone Jt Surg, vol.95, pp.980-988, 2013.

H. Li, J. J. Hicks, L. Wang, N. Oyster, M. J. Philippon et al., Customized platelet-rich plasma with transforming growth factor b1 neutralization antibody to reduce fibrosis in skeletal muscle, Biomaterials, vol.87, pp.147-56, 2016.

J. Clouet, M. Fusellier, A. Camus, L. Visage, C. Guicheux et al., Intervertebral disc regeneration: from cell therapy to the development of novel bioinspired endogenous repair strategies, Adv Drug Deliv Rev, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01843976

H. Kumar, D. Ha, E. Lee, J. H. Park, J. H. Shim et al., Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study, Stem Cell Res Ther, vol.8, p.262, 2017.

K. A. Pettine, R. K. Suzuki, T. T. Sand, and M. B. Murphy, Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year ARTICLE, PRESS Proceedings, vol.17

, Int Orthop, vol.41, pp.2097-103, 2017.

D. C. Noriega, F. Ardura, R. Hern-andez-ramajo, M. In-ferrero, and M. ,

A. Lite, I. Toribio, and B. , Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial, Transplantation, vol.101, pp.1945-51, 2017.

H. Kumar, D. Ha, E. Lee, J. H. Park, J. H. Shim et al., Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study, Stem Cell Res Ther, vol.8, p.262, 2017.

P. Colombier, J. Clouet, C. Boyer, M. Ruel, G. Bonin et al., TGF-b1 and GDF5 Act Synergistically to Drive the Differentiation of Human Adipose Stromal Cells toward Nucleus Pulposus-like Cells, Stem Cells, vol.34, pp.653-67, 2016.

J. Chahla, M. E. Cinque, N. S. Piuzzi, S. Mannava, A. G. Geeslin et al., A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting, J Bone Jt Surg, vol.99, pp.1769-79, 2017.

N. S. Piuzzi, Letter to the Editor, Clin Orthop Relat Res, vol.476, pp.1126-1134, 2018.

M. Dominici, L. Blanc, K. Mueller, I. Slaper-cortenbach, I. Marini et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, pp.315-322, 2006.

I. R. Murray, A. G. Geeslin, E. B. Goudie, F. A. Petrigliano, and R. F. Laprade, Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells, J Bone Joint Surg Am, vol.99, pp.809-828, 2017.

A. Standard, Test Method for Automated Colony Forming Unit (CFU) Assays-Image Acquisition and Analysis Method for Enumerating and Characterizing Cells and Colonies in Culture, ASTM Int, vol.2012, pp.1-11

M. A. Qadan, N. S. Piuzzi, C. Boehm, W. Bova, M. Moos et al., Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue, Cytotherapy, vol.20, pp.343-60, 2018.

T. W. Bauer, Stem Cell Therapy for Knee Pain-What Exactly Are We Injecting, and Why?, J Bone Joint Surg Am, vol.98, pp.1509-1519, 2016.

, The Regenerative Medicine Standards Landscape, 2018.

E. E. Godwin, N. J. Young, J. Dudhia, I. C. Beamish, and R. Smith, Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon, Equine Vet J, vol.44, pp.25-32, 2012.

R. Smith, Mesenchymal stem cell therapy for equine tendinopathy, Disabil Rehabil, vol.30, pp.1752-1760, 2008.

D. J. Ferris, D. D. Frisbie, J. D. Kisiday, C. W. Mcilwraith, B. A. Hague et al., Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury, Vet Surg, vol.43, pp.255-65, 2014.

P. Becerra, M. A. Vald, J. Dudhia, A. R. Fiske-jackson, F. Neves et al., Distribution of injected technetium(99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy, J Orthop Res, vol.31, pp.1096-102, 2013.

S. Broeckx, M. Zimmerman, S. Crocetti, M. Suls, T. Mari?-en et al., Regenerative Therapies for Equine Degenerative Joint Disease: A Preliminary Study, PLoS One, vol.9, 2014.

C. W. Mcilwraith, D. D. Frisbie, W. G. Rodkey, J. D. Kisiday, N. M. Werpy et al., Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects, Arthroscopy, vol.27, pp.1552-61, 2011.

A. C. Colbath, S. W. Dow, J. N. Phillips, C. W. Mcilwraith, and L. R. Goodrich, Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro, Stem Cells Dev, vol.26, pp.503-514, 2017.

J. Textor, Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein, Vet Clin North Am Equine Pract, vol.27, pp.275-98, 2011.

M. Waselau, W. W. Sutter, R. L. Genovese, and A. L. Bertone, Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses, J Am Vet Med Assoc, vol.232, pp.1515-1535, 2008.

D. D. Frisbie, C. E. Kawcak, N. M. Werpy, R. D. Park, and C. W. Mcilwraith, Clinical, biochemical, and histologic effects of intraarticular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis, Am J Vet Res, vol.68, pp.290-296, 2007.

A. L. Bertone, A. Ishihara, L. J. Zekas, M. L. Wellman, K. B. Lewis et al., Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses, Am J Vet Res, vol.75, pp.141-51, 2014.

N. Saulnier, J. Loriau, M. Febre, C. Robert, R. Rakic et al., Canine placenta: a promising potential source of highly proliferative and immunomodulatory mesenchymal stromal cells?, Vet Immunol Immunopathol, vol.171, pp.47-55, 2016.

S. H. Bogers, Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know, Front Vet Sci, vol.5, p.70, 2018.

A. J. Friedenstein, I. I. Piatetzky-shapiro, and K. V. Petrakova, Osteogenesis in transplants of bone marrow cells, J Embryol Exp Morphol, vol.16, pp.381-90, 1966.

A. J. Friedenstein, Precursor cells of mechanocytes, Int Rev Cytol, vol.47, pp.327-59, 1976.

A. J. Friedenstein, R. K. Chailakhjan, and K. S. Lalykina, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, Cell Tissue Kinet, vol.3, pp.393-403, 1970.

T. M. Dexter, T. D. Allen, and L. G. Lajtha, Conditions controlling the proliferation of haemopoietic stem cells in vitro, J Cell Physiol, vol.91, pp.335-379, 1977.

M. Owen and A. J. Friedenstein, Stromal stem cells: marrowderived osteogenic precursors, Ciba Found Symp, vol.136, pp.42-60, 1988.

A. In-press,

N. S. Piuzzi,

A. I. Caplan, Mesenchymal stem cells, J Orthop Res, vol.9, pp.641-50, 1991.

D. J. Prockop, Marrow stromal cells as stem cells for nonhematopoietic tissues, Science, vol.276, pp.71-75, 1997.

M. F. Pittenger, A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas et al., Multilineage potential of adult human mesenchymal stem cells, Science, vol.284, pp.143-150, 1999.

Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt, R. E. Schwartz, C. D. Keene et al., Pluripotency of mesenchymal stem cells derived from adult marrow, Nature, vol.418, pp.41-50, 2002.

D. 'souza, N. Rossignoli, F. Golinelli, G. Grisendi, G. Spano et al., Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies, BMC Med, vol.13, p.186, 2015.

D. G. Phinney and D. J. Prockop, Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair-Current Views, Stem Cells, vol.25, pp.2896-902, 2007.

M. B. Murphy, K. Moncivais, and A. I. Caplan, Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine, Exp Mol Med, vol.45, 2013.

E. M. Horwitz, L. Blanc, K. Dominici, M. Mueller, I. Slapercortenbach et al., Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement, Cytotherapy, vol.7, pp.393-398, 2005.

A. I. Caplan and D. Correa, The MSC: an injury drugstore, Cell Stem Cell, vol.9, pp.11-16, 2011.

G. F. Muschler and R. J. Midura, Connective tissue progenitors: practical concepts for clinical applications, Clin Orthop Relat Res, vol.1, pp.66-80, 2002.

J. Seita and I. L. Weissman, Hematopoietic stem cell: self-renewal versus differentiation, Wiley Interdiscip Rev Syst Biol Med, vol.2, pp.640-53, 2010.

K. Szade, G. S. Gulati, C. Chan, K. S. Kao, M. Miyanishi et al., Where Hematopoietic Stem Cells Live: The Bone Marrow Niche, Antioxid Redox Signal, vol.29, issue.2, pp.191-204, 2018.

L. J. Haseler, R. R. Sibbitt, W. L. Sibbit, A. A. Michael, C. M. Gasparovic et al., Syringe and Needle Size, Syringe Type, Vacuum Generation, and Needle Control in Aspiration Procedures, Cardiovasc Interv Radiol, vol.34, pp.590-600, 2011.

G. F. Muschler, C. Boehm, and K. Easley, Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume, J Bone Joint Surg Am, vol.79, pp.1699-709, 1997.

H. Castro-malaspina, W. Ebell, and S. Wang, Human bone marrow fibroblast colony-forming units (CFU-F), Prog Clin Biol Res, vol.154, pp.209-245, 1984.

H. Castro-malaspina, R. E. Gay, G. Resnick, N. Kapoor, P. Meyers et al., Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny, Blood, vol.56, pp.289-301, 1980.

P. Bianco and P. G. Robey, Skeletal stem cells, Development, vol.142, pp.1023-1030, 2015.

P. Robey, Mesenchymal stem cells": fact or fiction, and implications in their therapeutic use, F1000Research, vol.6, 2017.

K. G. Chen, K. R. Johnson, R. Mckay, and P. G. Robey, Concise Review: Conceptualizing Paralogous Stem-Cell Niches and Unfolding Bone Marrow Progenitor Cell Identities, Stem Cells, vol.36, pp.11-21, 2018.

A. R. Amini, C. T. Laurencin, and S. P. Nukavarapu, Bone tissue engineering: recent advances and challenges, Crit Rev Biomed Eng, vol.40, pp.363-408, 2012.

P. W. Andrews, J. Cavanagro, R. Deans, E. Feigel, E. Horowitz et al., Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells, Nat Biotechnol, vol.32, pp.724-730, 2014.

L. Surdo, J. Bauer, and S. R. , Quantitative Approaches to Detect Donor and Passage Differences in Adipogenic Potential and Clonogenicity in Human Bone Marrow-Derived Mesenchymal Stem Cells, Tissue Eng Part C Methods, vol.18, pp.877-89, 2012.

J. Galipeau, M. Krampera, J. Barrett, F. Dazzi, R. J. Deans et al., International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials, Cytotherapy, vol.18, pp.151-160, 2016.

B. Sacchetti, A. Funari, C. Remoli, G. Giannicola, G. Kogler et al., No Identical "Mesenchymal Stem Cells" at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels, Stem Cell Reports, vol.6, pp.897-913, 2016.

P. G. Robey, S. A. Kuznetsov, M. Riminucci, P. Bianco, and . Skeletal, mesenchymal") Stem Cells for Tissue Engineering, Methods Mol Med, vol.140, pp.83-99, 2007.

P. Bourin, B. A. Bunnell, L. Casteilla, M. Dominici, A. J. Katz et al., Stromal cells from the adipose tissuederived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT), Cytotherapy, vol.15, pp.641-649, 2013.

S. Statement, , 2018.

D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, PLoS Med, vol.6, 2009.

A. Liberati, D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gøtzsche et al., The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration, PLoS Med, vol.6, 2009.

I. Martin, H. Baldomero, A. Tyndall, and D. Niederwieser, Gratwohl A. A survey on cellular and engineered tissue therapies in Europe in 2008, Tissue Eng Part A, vol.16, pp.2419-2446, 2010.

H. Ireland, M. Gay, H. Baldomero, D. Angelis, B. Baharvand et al., The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015, Cytotherapy, vol.20, pp.1-20, 2018.

, Survey of cellular therapy and regenerative medicine in Europe-Patients Treated in 2016-ISCT n

, cellular-therapy-and-regenerative-medicine-in-EuropePatients-Treated-in-2016.htm, 2018.

C. Chu, S. Rodeo, N. Bhutani, L. Goodrich, J. Huard et al., Optimizing Clinical Use of Biologics in Orthopedic Surgery: Consensus Recommendations from the 2018 AAOS/NIH U-13 Symposium, J Am Acad Orthop Surg, 2018.

C. R. Chu, Optimizing Clinical Use of Biologics in Orthopedic Surgery: Consensus Recommendations from the 2018 AAOS/NIH U-13 Symposium, J Am Acad Orthop Surg, 2018.

H. A. Prentice, M. Lind, C. Mouton, A. Persson, H. Magnusson et al., Patient demographic and surgical characteristics in anterior cruciate ligament reconstruction: a description of registries from six countries, Br J Sports Med, vol.52, pp.716-738, 2018.

C. D. Etkin and B. D. Springer, The American Joint Replacement Registry-the first 5 years, Arthroplast Today, vol.3, pp.67-76, 2017.
DOI : 10.1016/j.artd.2017.02.002
URL : https://doi.org/10.1016/j.artd.2017.02.002

G. Xiong, N. Lingampalli, J. Koltsov, L. L. Leung, N. Bhutani et al., Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma, Am J Sports Med, vol.46, pp.409-428, 2018.

K. P. Spindler, R. D. Parker, J. T. Andrish, C. C. Kaeding, R. W. Wright et al., Prognosis and predictors of ACL reconstructions using the MOON cohort: a model for comparative effectiveness studies, J Orthop Res, vol.31, pp.2-9, 2013.

R. W. Wright, L. J. Huston, K. P. Spindler, W. R. Dunn, A. K. Haas et al., Descriptive Epidemiology of the Multicenter ACL Revision Study (MARS) Cohort, Am J Sports Med, vol.38, pp.1979-86, 2010.

C. R. Chu, B. D. Beynnon, J. L. Dragoo, G. S. Fleisig, J. M. Hart et al., The Feasibility of Randomized Controlled Trials for Early Arthritis Therapies (EARTH) Involving Acute Anterior Cruciate Ligament Tear Cohorts, Am J Sports Med, vol.40, pp.2648-52, 2012.

A. In-press,

N. S. Piuzzi,